Some investors asked Kaisai Biotech how was the production capacity of the three types of high-temperature polyamide, long-chain polyamide, and PA56 planned for the company's “500,000 tons of bio-based pentanediamine per year and 900,000 tons of bio-based polyamide project” in Shanxi? On October 27, the company replied that the company has formed a corresponding production capacity layout in the polyamide field.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.